| RS2528427978 |
CENPF
|
Health Risk |
Pathogenic |
— |
| RS2528428172 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2528428435 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS2528434640 |
CENPF
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 29, Primary ciliary dyskinesia 29 |
| RS2528435160 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2528435379 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2528435985 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS2528436006 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS2528436693 |
MTR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS2528443064 |
SDCCAG8
|
Health Risk |
Likely pathogenic |
Senior-Loken syndrome 7, Bardet-Biedl syndrome 16 |
| RS2528455666 |
SDCCAG8
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2528456354 |
SDCCAG8
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 16, Senior-Loken syndrome 7 |
| RS2528483163 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS2528487643 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia |
| RS2528491247 |
LRP2
|
Health Risk |
Likely pathogenic |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS2528507871 |
RYR2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2528508198 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2528509856 |
SLC1A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome, Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome |
| RS2528509885 |
SLC1A4
|
Health Risk |
Pathogenic |
— |
| RS2528510595 |
SLC1A4
|
Health Risk |
Likely pathogenic |
Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome, Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome |
| RS2528510808 |
SLC1A4
|
Health Risk |
Pathogenic |
— |
| RS2528511199 |
SLC1A4
|
Health Risk |
Pathogenic |
— |
| RS2528521189 |
IL1R1
|
Health Risk |
Pathogenic |
Chronic recurrent multifocal osteomyelitis 3, Chronic recurrent multifocal osteomyelitis 3 |
| RS2528522105 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS2528523329 |
IRF2BP2
|
Health Risk |
Likely pathogenic |
Immunodeficiency, common variable |
| RS2528524023 |
MTR
|
Health Risk |
Likely pathogenic |
MTR-related disorder, MTR-related disorder |
| RS2528524093 |
IRF2BP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency, common variable |
| RS2528527318 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS2528532731 |
SLC39A4
|
Health Risk |
Pathogenic |
— |
| RS2528537363 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS2528537380 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS2528547442 |
CACNA1E
|
Health Risk |
Likely pathogenic |
— |
| RS2528548650 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2528548714 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS2528559979 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS2528560334 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2528561476 |
SLC1A4
|
Health Risk |
Likely pathogenic |
SLC1A4-related disorder, SLC1A4-related disorder |
| RS2528567165 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS2528568304 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2528575772 |
SLC1A4
|
Health Risk |
Pathogenic |
— |
| RS2528576121 |
SLC1A4
|
Health Risk |
Likely pathogenic |
Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome, Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome |
| RS2528576268 |
SLC1A4
|
Health Risk |
Pathogenic |
— |
| RS2528576487 |
SLC1A4
|
Health Risk |
Pathogenic |
— |
| RS2528576536 |
SLC1A4
|
Health Risk |
Pathogenic |
— |
| RS2528609545 |
RAB3GAP2
|
Health Risk |
Likely pathogenic |
Martsolf syndrome 1, Martsolf syndrome 1 |
| RS2528609674 |
RAB3GAP2
|
Health Risk |
Pathogenic |
Martsolf syndrome, Warburg micro syndrome 2 |
| RS2528612732 |
PI4KB
|
Health Risk |
Pathogenic |
Hearing loss, autosomal dominant 87 |
| RS2528617056 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS2528617066 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS2528617075 |
LRP2
|
Health Risk |
Likely pathogenic |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS2528617080 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2528619145 |
RAB3GAP2
|
Health Risk |
Likely pathogenic |
— |
| RS2528620919 |
PI4KB
|
Health Risk |
Pathogenic |
Hearing loss, autosomal dominant 87 |
| RS2528640993 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS2528662363 |
RAB3GAP2
|
Health Risk |
Likely pathogenic |
Martsolf syndrome 1, Martsolf syndrome 1 |
| RS2528663434 |
RAB3GAP2
|
Health Risk |
Likely pathogenic |
RAB3GAP2-related disorder, RAB3GAP2-related disorder |
| RS2528671145 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS2528671501 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2528681294 |
RAB3GAP2
|
Health Risk |
Pathogenic |
Martsolf syndrome, Warburg micro syndrome 2 |
| RS2528685221 |
RAB3GAP2
|
Health Risk |
Likely pathogenic |
Warburg micro syndrome 2, Warburg micro syndrome 2 |
| RS2528685282 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528686227 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528686333 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528686401 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528687024 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528687444 |
MSH2
|
Health Risk |
Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2528688020 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2528688225 |
MSH2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528688474 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528688731 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Hereditary nonpolyposis colon cancer |
| RS2528688924 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528690308 |
RAB3GAP2
|
Health Risk |
Likely pathogenic |
Warburg micro syndrome 2, Warburg micro syndrome 2 |
| RS2528690648 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528691205 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528691581 |
CACNA1E
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS2528692371 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528692611 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528692699 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS2528692746 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528693208 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528693564 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528693698 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528693860 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528720999 |
IGKC
|
Health Risk |
Pathogenic |
Recurrent infections associated with rare immunoglobulin isotypes deficiency, Recurrent infections associated with rare immunoglobulin isotypes deficiency |
| RS2528725105 |
ABHD5
|
Health Risk |
Likely pathogenic |
ABHD5-related disorder, ABHD5-related disorder |
| RS2528725124 |
RAB3GAP2
|
Health Risk |
Pathogenic |
Martsolf syndrome, Warburg micro syndrome 2 |
| RS2528737257 |
ABHD5
|
Health Risk |
Pathogenic |
— |
| RS2528738360 |
LARS2
|
Health Risk |
Pathogenic |
— |
| RS2528738855 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528738902 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS2528738944 |
AGXT
|
Health Risk |
Pathogenic |
— |
| RS2528738955 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528738978 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS2528739107 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528739362 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, Primary hyperoxaluria |
| RS2528739914 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528739939 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS2528739981 |
AGXT
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary hyperoxaluria, type I |
| RS2528739984 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528740066 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |